California 2025-2026 Regular Session

California Assembly Bill AB309

Introduced
1/23/25  
Refer
2/10/25  
Report Pass
4/9/25  
Refer
2/10/25  
Refer
4/9/25  
Refer
4/9/25  
Report Pass
4/23/25  
Engrossed
5/15/25  
Refer
5/15/25  
Refer
5/28/25  
Report Pass
6/19/25  
Refer
6/19/25  
Report Pass
7/14/25  
Refer
7/14/25  
Enrolled
9/3/25  
Chaptered
10/13/25  

Caption

Hypodermic needles and syringes.

Impact

The legislative discussions around AB 309 revealed a strong focus on harm reduction strategies in public health. By removing the expiration date, California is solidifying its commitment to fight infectious diseases linked to syringe use. This bill not only simplifies access to syringes for those in need but also ensures that pharmacies are required to provide essential counseling and disposal options for used needles. This potentially increases public resources available for health education and decreases stigma attached to obtaining syringes.

Summary

Assembly Bill 309, introduced by Zbur, aims to extend indefinitely provisions related to the furnishing of hypodermic needles and syringes by pharmacists and physicians to individuals aged 18 and older without the need for a prescription or permit. The bill seeks to continue existing public health measures that help prevent the transmission of HIV, viral hepatitis, and other bloodborne diseases among syringe users. Until now, these provisions were set to expire on January 1, 2026, but the bill's enactment will extend these lifesaving measures indefinitely.

Sentiment

The sentiment surrounding AB 309 appears to be largely positive among public health advocates who argue that this bill plays a crucial role in minimizing the spread of infections and improving community health outcomes. Supporters voice strong agreement on the importance of maintaining access to hypodermic needles, citing the necessity to provide safe options for drug users and to prevent harm. However, some opposition exists regarding concerns over facilitating drug use, highlighting a division in viewpoints on managing drug dependency in communities.

Contention

One notable point of contention in the discussions was the lack of reimbursement requirements for local agencies or school districts, as this caused concern over the fiscal implications of the state's mandate on local resources. Critics argue that while public health is imperative, local governments should not bear the costs associated with expanded access to hypodermic needles. Furthermore, discussions also touched on the proper management and disposal of used syringes, emphasizing the need for adequate safety protocols.

Companion Bills

No companion bills found.

Previously Filed As

CA AB37

Furnishing hypodermic needles and syringes.

CA AB396

Needle and syringe exchange services.

CA AB1037

Public health: substance use disorder.

CA SB6

An act to amend Sections 11014.

CA AB1794

Pharmacy: enteral nutrition supplements or replacements.

CA HB2697

Expired opioid antagonists; use

CA SB249

An Act To Amend Title 16 And Title 29 Of The Delaware Code Relating To Substance Use Harm Reduction.

CA AB1503

Pharmacy.

CA AB754

Floating home marinas: rent caps: County of Marin.

CA SB00195

An Act Concerning The Prevention Of Accidental Overdose Deaths And Improving Access To Treatment And Recovery Services For Substance Use Disorder.

Similar Bills

CA AB37

Furnishing hypodermic needles and syringes.

CA AB1037

Public health: substance use disorder.

AZ HB2697

Expired opioid antagonists; use

CA AB1794

Pharmacy: enteral nutrition supplements or replacements.

CA AB396

Needle and syringe exchange services.

CT SB01285

An Act Establishing An Overdose Prevention Center Pilot Program.

CT SB00195

An Act Concerning The Prevention Of Accidental Overdose Deaths And Improving Access To Treatment And Recovery Services For Substance Use Disorder.

DE SB249

An Act To Amend Title 16 And Title 29 Of The Delaware Code Relating To Substance Use Harm Reduction.